“THE COMPREHENSIVE COMPARISON OF THE EFFICACY OF FIRST-LINE DRUGS IN THE TREATMENT OF TYPE II DIABETES: METFORMIN, GLP-1 AGONISTS, AND SGLT2 INHIBITORS”, IJITSS, vol. 6, no. 3(47), Sep. 2025, doi: 10.31435/ijitss.3(47).2025.3884.